Sa1813 - MSI-L/EMAST, a Poor Outcome Biomarker for Colorectal Cancer Patients, is Present in Young Ulcerative Colitis Patients that Require High Doses of Anti-Inflammatory Agents, and Shows Clonality
- Resource Type
- Abstract
- Source
- In
Gastroenterology April 2017 152(5) Supplement 1:S355-S356 - Subject
- Language
- ISSN
- 0016-5085